PROCEPT BioRobotics Corporation growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +29.3%
EBITDA: -14.2%
EBIT: -13.1%
EPS: -7.1%
Free cash flow: +8.7%
Operating cash flow: +16.4%

Forward estimates

Revenue: +38.0%
EBITDA: +298.0%
EPS: +35.5%

Three-year CAGR

Revenue: +60.1%
EBITDA: -4.2%
EBIT: -7.5%
Net income: -4.5%
EPS: +1.7%
Free cash flow: +43.7%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.